Original article by Eryk Bagshaw, Amy Corderoy
The Sydney Morning Herald – Page: 11 : 18-Sep-14

Law firm Maurice Blackburn will seek to appeal a Federal Court ruling which found that private companies can patent human genes. The case concerned Myriad Genetics’ application for a patent over the BRCA1 gene, which is associated with breast cancer. Maurice Blackburn will argue that the court erred in concluding that the process of identifying a gene constitutes a form of manufacturing

CORPORATES
MAURICE BLACKBURN PTY LTD, FEDERAL COURT OF AUSTRALIA, HIGH COURT OF AUSTRALIA, MYRIAD GENETICS INCORPORATED, JONES DAY